ICYMI: Friday Roll Up

Dr. Amy Abernethy. Photo courtesy of TedMed
Kathryn Blume 26 May 2019

“I know that there is great public interest in the development of therapies/other consumer products derived from cannabis. A big topic is cannabidiol (CBD) & a key question is how we, as FDA, are going to address this.” – Dr. Amy Abernethy, Principal Deputy Commissioner, Acting CIO, USFDA

Welcome To The Weekly Roll Up – A Compendium of The Week’s Cannabis News


In Their Own Words: Testimonies From The Statehouse

Correction: Former Dem Party Chair No Longer President Of CVD

VTCANN 2019 Photo Highlights

At Vt. Cannabis And Hemp Convention, Some Businesses Having #FOMO

The Cannabis Catch-Up: Better Luck Next Year?

Help sought for state colleges; hemp may be future of agriculture

Future Farm Signs Agreement With Hemp Lab/CBD Oil Processing Company

It’s legal, but you can’t purchase it legally




 New Hampshire

 New Jersey

 New York













 Food & Bev

 Growing and Making

 Higher Ed


 Hypocrisy, Prevarication, and Outright Lies


 Law Enforcement 






 Presidential Campaign



 Social Justice

 Social Media 




























 North Carolina




 Puerto Rico

 Rhode Island






 Washington, D.C.

 West Virginia














 North Macedonia

 Trinidad and Tobago 


Pass this post:

Related Posts